Retour aux projets

9949.1;5 PFLS-LS

Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.

Résumé

Development of small molecule inhibitors of the respiratory syncytial virus polymerase complex.

Textes supplémentaires

Abstract

Respiratory syncytial virus (RSV) is the principal cause of lower respiratory disease in infants and children necessitating 75,000 hospitalizations per year in the US alone. Despite its importance as a pathogen, there is neither a treatment nor a vaccine against RSV available. The project partners will develop novel, first-in-class antiviral drug candidates disrupting the interaction between two proteins of the RSV replicase complex, which is crucial for virus propagation.

Participants

Pius August Schubiger

Kontaktperson

august.schubiger@pharma.ethz.ch

ETH Zürich Pius August Schubiger Wolfgang-Pauli-Strasse 10 Institut für Pharmazeutische Wissen 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2009-01-31
Date de fin
2014-02-13
Coûts totaux approuvés
CHF 351051.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T115 Medical technology 100.0%